Insider Transactions in Q4 2022 at Aerie Pharmaceuticals Inc (AERI)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 21
2022
|
Raj Kannan Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
215,783
-100.0%
|
$3,236,745
$15.25 P/Share
|
|
Nov 21
2022
|
Jeffrey Calabrese Vice President of Finance |
SELL
Sale (or disposition) back to the issuer
|
Direct |
18,585
-100.0%
|
$278,775
$15.25 P/Share
|
|
Nov 21
2022
|
Richard Croarkin Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
16,095
-100.0%
|
$241,425
$15.25 P/Share
|
|
Nov 21
2022
|
Michael Du Toit Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
16,095
-100.0%
|
$241,425
$15.25 P/Share
|
|
Nov 21
2022
|
David W Gryska Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
1,996
-100.0%
|
$29,940
$15.25 P/Share
|
|
Nov 21
2022
|
David W Gryska Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
11,495
-100.0%
|
$172,425
$15.25 P/Share
|
|
Nov 21
2022
|
John La Rocca General Counsel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
53,585
-100.0%
|
$803,775
$15.25 P/Share
|
|
Nov 21
2022
|
Peter Frederick Lang Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
46,297
-100.0%
|
$694,455
$15.25 P/Share
|
|
Nov 21
2022
|
Casey C. Kopczynski Chief Scientific Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
280,244
-100.0%
|
$4,203,660
$15.25 P/Share
|
|
Nov 21
2022
|
Peter J Mc Donnell Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,995
-100.0%
|
$119,925
$15.25 P/Share
|
|
Nov 21
2022
|
Benjamin F Mcgraw Iii Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
41,984
-100.0%
|
$629,760
$15.25 P/Share
|
|
Nov 21
2022
|
Julie Mc Hugh Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
16,095
-100.0%
|
$241,425
$15.25 P/Share
|
|
Nov 01
2022
|
Jeffrey Calabrese Vice President of Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
179
-0.95%
|
$2,685
$15.22 P/Share
|